Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.2.2024G.V.Pharma, a.s. (GVP)51019V PNC 750 (tbl flm 30x750 mg (blister))20.2.2023O
 20.2.2024Novartis Europharm Limited (NEH-IE)9172BEXJADE 180 mg filmom obalené tablety (tbl flm 30x180 mg (blis. PVC/PVDC/Al))30.4.2024Z
 20.2.2024Novartis Europharm Limited (NEH-IE)9175BEXJADE 360 mg filmom obalené tablety (tbl flm 30x360 mg (blis. PVC/PVDC/Al))15.1.2024Z
 20.2.2024Novartis Europharm Limited (NEH-IE)03907AZOPT 10 mg/ml, očné suspenzné kvapky (int opu 1x5 ml (fľ.PE))20.2.2024O
 19.2.2024Sandoz GmbH (SAN-A)74987Baneocin (ung der 1x20 g (tuba Al))16.2.2024R
 19.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)12736Doxyhexal 200 Tabs (tbl 20x200 mg (blis.PP/Al))12.2.2024O
 19.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)12742Doxyhexal Tabs (tbl 20x100 mg (blis.PP/Al))12.2.2024O
 19.2.2024Takeda GmbH (TKD-3)34804CONTROLOC i.v. (plv ino 10x40 mg (liek.skl.-nem.bal.))19.2.2024U
 19.2.2024Medreg s.r.o. (MRG-2)5191DEplerenon Medreg 25 mg (tbl flm 90x25 mg (blis.PVC/PVDC/Al))8.2.2024U
 19.2.2024Medreg s.r.o. (MRG-2)5211DEplerenon Medreg 50 mg (tbl flm 30x50 mg (blis.PVC/PVDC/Al))8.2.2024U
 19.2.2024B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))19.2.2024R
 16.2.2024MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))12.2.2024R
 16.2.2024MEDOCHEMIE Ltd. (MOE)46243MEDOTRIGIN 100 mg (tbl 30x100 mg)12.2.2024O
 16.2.2024MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))12.2.2024O
 16.2.2024MEDOCHEMIE Ltd. (MOE)54423MAGRILAN 20 mg (cps dur 30x20 mg (blis.PVC/Al))12.2.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)